Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
Conference Program for 2022 the World Conference on Lung Cancer
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2137
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
IS03 - Industry Symposium Sponsored by Mirati Therapeutics: Future Directions in NSCLC: Tailoring Treatment Options
- 12:00 - 13:00
- 8/06/2022
- Location: Hall C2
- Not for CME Credit
- Type: Industry Symposium
- Track: N/A
-
+
IS03.02 - New Approaches for Overcoming CPI Resistance in NSCLC
12:05 - 12:15 | Presenter: David Carbone
- Abstract
Loading...
-
+
EP03.01 - Epidemiology
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Epidemiology
-
+
EP03.01-014 - Results From the BEWELL Study: Black Raspberry Nectar for the Prevention of Lung Cancer (NCT04267874)
Presenter: Marisa BIttoni- Abstract
Loading...
-
+
EP08.01 - Metastatic Non-small Cell Lung Cancer - Immunotherapy
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
-
+
EP08.01-019 - Modifiable biomarkers of response to immune checkpoint inhibitor treatment in non-small cell lung cancer
Presenter: Daniel Spakowicz- Abstract
Loading... -
+
EP08.01-062 - Body Mass Index, Immune Related Adverse Events, and Survival in Patients with Metastatic Non-small Cell Lung Cancer Treated with Immunotherapy
Presenter: Mingjia Li- Abstract
Loading... -
+
EP08.01-098 - Evaluating Risk Factors for Pneumonitis in Stage III NSCLC Patients Receiving Durvalumab after Definitive Chemoradiation
Presenter: xiaokui Mo- Abstract
Loading...
-
+
EP14.05 - Small Cell Lung Cancer and Neuro-endocrine Tumors - RW/SOC
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Small Cell Lung Cancer and Neuro-endocrine Tumors - RW/SOC
-
+
EP14.05-004 - Temozolomide and Atezolizumab as Second Line Treatment for Extensive Stage Small Cell Lung Cancer: A Randomized, Multi-Cohort Phase 2 Trial
Presenter: Dwight H Owen- Abstract
Loading...
-
+
EP16.03 - Tumor Biology and Biomarkers - Molecular Profiling and Targeted Therapeutics
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Tumor Biology and Biomarkers - Molecular Profiling and Targeted Therapeutics
-
+
EP16.03-009 - Patterns of KEAP1 Genomic Co-alterations in Advanced Non-small Cell Lung Cancer Identified by Plasma-Based Genyotyping
Presenter: Dwight H Owen- Abstract
Loading...
-
+
P1.03 - Early Detection and Screening - Pulmonary Nodule
- 17:00 - 19:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: Regular Poster
- Track: Early Detection and Screening - Pulmonary Nodule
-
+
P1.03-01 - Do We Follow Incidental Lung Nodules Appropriately? A Retrospective Study
Presenter: Jasleen Kaur Pannu- Abstract
Loading...
-
+
P1.15 - Metastatic Non-small Cell Lung Cancer - Immunotherapy
- 17:00 - 19:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: Regular Poster
- Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
-
+
P1.15-08 - Phase 1: IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy as Monotherapy or in Combination with Atezolizumab, in Adults with Non-Small Cell Lung Cancer
Presenter: Michael Boyer- Abstract
Loading...
-
+
OA12 - Novel and Combination Strategies for SCLC
- 16:00 - 17:00
- 8/08/2022
- Location: Hall C8
- Not for CME Credit
- Type: Oral
- Track: Small Cell Lung Cancer and Neuro-Endocrine Tumors
- Moderators:Alessandra Curioni-Fontecedro, Kostas Syrigos
-
+
OA12.04 - Efficacy of Nivolumab and Temozolomide in Extensive Stage Small Cell Lung Cancer after Chemo-Immunotherapy: A Phase 2 Trial.
16:12 - 16:22 | Presenter: Dwight H Owen
- Abstract
Loading...
-
+
ES34 - Updates in Radiology, Pulmonology, and Staging
- 12:00 - 13:00
- 8/09/2022
- Location: Strauss 1/2
- IASLC CME Accredited
- Type: Education Session
- Track: Pulmonology, Radiology, and Staging
- Moderators:Lynette Teo, David Carbone
-
+
Session Moderator
12:00 - 12:00 | Presenter: Lynette Teo
- Abstract
Loading... -
+
Session Moderator
12:00 - 12:00 | Presenter: David Carbone
- Abstract
Loading... -
+
Session Moderator
12:50 - 13:00 | Presenter: ANKUSH JAJODIA
- Abstract
Loading... -
+
ES34.01 - Session Introduction
12:00 - 12:01 | Presenter: Lynette Teo
- Abstract
Loading... -
+
ES34.02 - Session Introduction
12:01 - 12:02 | Presenter: ANKUSH JAJODIA
- Abstract
Loading... -
+
ES34.02 - Session Introduction
12:01 - 12:02 | Presenter: David Carbone
- Abstract
Loading... -
+
ES34.03 - Advances in Lung Cancer Imaging
12:02 - 12:14 | Presenter: Jin Mo Goo
- Abstract
Loading... -
+
ES34.04 - Diagnostic and Interventional Bronchoscopy: Updates and Future
12:14 - 12:26 | Presenter: Daniela Gompelmann
- Abstract
Loading... -
+
ES34.05 - TNM Staging: Essential and Other Emerging Concepts
12:26 - 12:38 | Presenter: Ramon Rami-Porta
- Abstract
Loading... -
+
ES34.05 - TNM Staging: Essential and Other Emerging Concepts
12:26 - 12:38 | Presenter: David Carbone
- Abstract
Loading... -
+
ES34.06 - Inclusion of Molecular/Genetic Factors in the TNM Staging System, Is It Possible?
12:38 - 12:50 | Presenter: David Carbone
- Abstract
Loading... -
+
ES34.07 - Live Q&A
12:50 - 13:00
- Abstract
Loading...
-
+
OA14 - New Techniques to Improve Outcome in Early Stage NSCLC Patients Treated with Surgery or Radiotherapy
- 12:00 - 13:00
- 8/09/2022
- Location: Hall C8
- Not for CME Credit
- Type: Oral
- Track: Early Stage Non-small Cell Lung Cancer
- Moderators:Paul Van Schil, Fabio Moraes
-
+
OA14.06 - T-Cell Dynamics in Response to Neoadjuvant Atezolizumab in Early NSCLC by Antigen Response and T-Cell Receptor Sequencing
12:22 - 12:32 | Presenter: Filiz Oezkan
- Abstract
Loading...
